Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)

Giaccone, Giuseppe;Debruyne, Channa;Felip, Enriqueta;Chapman, Paul B.;Legrand, Catherine;et.al.
(2005) Journal of Clinical Oncology — Vol. 23, n° 28, p. 6854-6864 (2005)

Files

No attached file found for this publication.

Details

Authors
  • Giaccone, GiuseppeVrije Universiteit Medical Center
    Author
  • Debruyne, ChannaEORTC
    Author
  • Felip, EnriquetaVall d'Hebron University Hospital
    Author
  • Chapman, Paul B.Memorial Sloan-Kettering Cancer Center
    Author
  • Legrand, CatherineUCLouvain
    Author
  • et. al.
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Giaccone, G., Debruyne, C., Felip, E., Chapman, P. B., Grant, S. C., Millward, M., Thiberville, L., D’addario, G., Coens, C., Rome, L. S., Zatloukal, P., Masso, O., Legrand, C., & et al. (2005). Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). Journal of Clinical Oncology, 23(28), 6854-6864. https://doi.org/10.1200/JCO.2005.17.186 (Original work published 2005)